These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 19948843

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Resting heart rate is associated with cardiovascular and all-cause mortality after adjusting for inflammatory markers: the Copenhagen City Heart Study.
    Jensen MT, Marott JL, Allin KH, Nordestgaard BG, Jensen GB.
    Eur J Prev Cardiol; 2012 Feb; 19(1):102-8. PubMed ID: 21525123
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Plasma parathyroid hormone and the risk of cardiovascular mortality in the community.
    Hagström E, Hellman P, Larsson TE, Ingelsson E, Berglund L, Sundström J, Melhus H, Held C, Lind L, Michaëlsson K, Arnlöv J.
    Circulation; 2009 Jun 02; 119(21):2765-71. PubMed ID: 19451355
    [Abstract] [Full Text] [Related]

  • 31. Fibroblast growth factor 23 (FGF23) and mortality: the Ludwigshafen Risk and Cardiovascular Health Study.
    Brandenburg VM, Kleber ME, Vervloet MG, Tomaschitz A, Pilz S, Stojakovic T, Delgado G, Grammer TB, Marx N, März W, Scharnagl H.
    Atherosclerosis; 2014 Nov 02; 237(1):53-9. PubMed ID: 25200615
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Age- and sex-tailored serum phosphate thresholds do not improve cardiovascular risk estimation in CKD.
    Ferraro PM, Bonello M, Gambaro A, Sturniolo A, Gambaro G.
    J Nephrol; 2011 Nov 02; 24(4):446-52. PubMed ID: 21607913
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Associations between hearing impairment and mortality risk in older persons: the Blue Mountains Hearing Study.
    Karpa MJ, Gopinath B, Beath K, Rochtchina E, Cumming RG, Wang JJ, Mitchell P.
    Ann Epidemiol; 2010 Jun 02; 20(6):452-9. PubMed ID: 20470972
    [Abstract] [Full Text] [Related]

  • 40. Relation between serum fibroblast growth factor-23 level and mortality in incident dialysis patients: are gender and cardiovascular disease confounding the relationship?
    Olauson H, Qureshi AR, Miyamoto T, Barany P, Heimburger O, Lindholm B, Stenvinkel P, Larsson TE.
    Nephrol Dial Transplant; 2010 Sep 02; 25(9):3033-8. PubMed ID: 20368304
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.